Literature DB >> 1387884

Transfection of a glycosylated phosphatidylinositol-anchored folate-binding protein complementary DNA provides cells with the ability to survive in low folate medium.

C A Luhrs1, C A Raskin, R Durbin, B Wu, E Sadasivan, W McAllister, S P Rothenberg.   

Abstract

KB cells express a folate-binding protein that is anchored to the plasma membrane by a glycosylated phosphatidylinositol (GPI) tail and these cells can grow in medium containing a very low folate concentration (1 nM). In contrast, mouse 3T3 cells do not express a membrane-associated folate-binding protein and cannot grow under similar low folate conditions. In these studies, 3T3 cells were transfected with a vector containing the cDNA that codes for the KB cell folate-binding protein. In contrast to the wild-type 3T3 cells, the transfected 3T3 cells express a level of folate-binding protein similar to KB cells, 1 and 1.4 ng/micrograms protein, respectively. The capacity for binding [3H] folate to the surface of transfected 3T3 cells cultured in folate-deficient medium is 7.7 pmol/10(6) cells, and this is approximately 50% of the surface binding capacity of KG cells under similar culture conditions. Moreover, after treatment of the transfected 3T3 cells with phospholipase C specific for phosphatidylinositol, the binding of [3H] folate to the surface of these cells is reduced by 90%, indicating that, like the KB cells, the folate-binding protein is anchored to the plasma membrane by a GPI tail. Although the doubling time of wild-type 3T3 cells markedly increases after 13 d of culture in folate-deficient medium, the doubling time of both the transfected 3T3 cells and KB cells do not change. The results of these experiments indicate that the GPI-anchored folate-binding protein provides a mechanism to maintain a level of folate that permits the folate-dependent metabolic functions necessary for cell survival under low folate conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387884      PMCID: PMC329938          DOI: 10.1172/JCI115959

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Role of the membrane-associated folate binding protein (folate receptor) in methotrexate transport by human KB cells.

Authors:  J C Deutsch; P C Elwood; R M Portillo; M G Macey; J F Kolhouse
Journal:  Arch Biochem Biophys       Date:  1989-11-01       Impact factor: 4.013

Review 2.  Folate-binding proteins.

Authors:  C Wagner
Journal:  Nutr Rev       Date:  1985-10       Impact factor: 7.110

3.  A radioassay for serum folate: use of a two-phase sequential-incubation, ligand-binding system.

Authors:  S P Rothenberg; M DaCosta; Z Rosenberg
Journal:  N Engl J Med       Date:  1972-06-22       Impact factor: 91.245

Review 4.  Obligate genetic expression in tumor cells of a fetal membrane property mediating "folate" transport: biological significance and implications for improved therapy of human cancer.

Authors:  F M Sirotnak
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

5.  A critical intracellular concentration of fully reduced non-methylated folate polyglutamates prevents macrocytosis and diminished growth rate of human cell line K562 in culture.

Authors:  D Watkins; B A Cooper
Journal:  Biochem J       Date:  1983-08-15       Impact factor: 3.857

6.  Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells.

Authors:  A C Antony; M A Kane; R M Portillo; P C Elwood; J F Kolhouse
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

7.  Purified membrane and soluble folate binding proteins from cultured KB cells have similar amino acid compositions and molecular weights but differ in fatty acid acylation.

Authors:  C A Luhrs; P Pitiranggon; M da Costa; S P Rothenberg; B L Slomiany; L Brink; G I Tous; S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Inhibitory effects of probenecid on the individual transport routes which mediate the influx and efflux of methotrexate in L1210 cells.

Authors:  G B Henderson; E M Zevely
Journal:  Biochem Pharmacol       Date:  1985-05-15       Impact factor: 5.858

9.  Interaction of probenecid with methotrexate transport and release in the isolated rat hepatocyte in suspension.

Authors:  D A Gewirtz; J H Plotkin; J K Randolph
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

10.  Mediated uptake of folate by a high-affinity binding protein in sublines of L1210 cells adapted to nanomolar concentrations of folate.

Authors:  G B Henderson; J M Tsuji; H P Kumar
Journal:  J Membr Biol       Date:  1988-03       Impact factor: 1.843

View more
  5 in total

1.  Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo.

Authors:  X L Sun; B R Murphy; Q J Li; S Gullapalli; J Mackins; H N Jayaram; A Srivastava; A C Antony
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

2.  Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.

Authors:  Serkan Senol; Ayse Bahar Ceyran; Abdullah Aydin; Ebru Zemheri; Seyma Ozkanli; Duygu Kösemetin; Ibrahim Sehitoglu; Ibrahim Akalin
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Functional folate receptor alpha is elevated in the blood of ovarian cancer patients.

Authors:  Eati Basal; Guiti Z Eghbali-Fatourechi; Kimberly R Kalli; Lynn C Hartmann; Karin M Goodman; Ellen L Goode; Barton A Kamen; Philip S Low; Keith L Knutson
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

4.  Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease.

Authors:  Daniel J O'Shannessy; Elizabeth B Somers; Julia Maltzman; Robert Smale; Yao-Shi Fu
Journal:  Springerplus       Date:  2012-09-28

5.  Conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and women.

Authors:  Linda E Kelemen; James D Brenton; Christine Parkinson; Hayley C Whitaker; Anna M Piskorz; Ilona Csizmadi; Paula J Robson
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.